During the past decade, Saiseikai Fukuoka General Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saiseikai Fukuoka General Hospital" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Bayer" with 2 trials sponsored, "Japan Clinical Cancer Research Organization" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saiseikai Fukuoka General Hospital" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Korean Cancer Study Group" with 1 trials as a collaborator, "Population Health Research Institute" with 1 trials as a collaborator, "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Vivian L. Smith Foundation for Neurologic Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Saiseikai Fukuoka General Hospital" are "Diabetes Mellitus, Type 2" (2 trials), "Gastric Cancer" (2 trials), "Heart Failure" (2 trials), "Acute Non-cardioembolic Ischemic Stroke" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Saiseikai Fukuoka General Hospital" in a lesser frequency.

Most popular intervention types in "Saiseikai Fukuoka General Hospital" are "Drug" (13 trials), "Device" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Empagliflozin" (4 trials), "Adverse event" (1 trials), "BAY2433334" (1 trials) and "BAY2433334 matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saiseikai Fukuoka General Hospital" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Saiseikai Fukuoka General Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Saiseikai Fukuoka General Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Saiseikai Fukuoka General Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".